Therapeutic areas

Small Molecules

Biosimilars

Indication

Molecular target

Research

Pre-clinical

Clinical

Solid tumors
FGFR inhibitor
Solid tumors/hematology
Proteasome pathway inhibitor (UBA1)
Solid tumors/hematology
MER kinase inhibitor
MER
Behavioral disorders
5HT6 agonist
Drug-resistant depression
S - ketamine
Schizophrenia
PDE10A inhibitor
Depression
TrkB agonist
Astma/COPD
PI3K delta kinase inhibitor
Asthma/psoriasis
JAK/ROCK kinase inhibitor
Diabetes
rhFGF1 ligand
Diabetes/obesity
GPR40 agonist
Biosimilars
CHO (Lucentis)